Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 20 | 2022 | 680 | 4.310 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 1898 | 3.390 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2021 | 359 | 3.190 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2024 | 1170 | 2.290 |
Why?
|
| Pediatrics | 12 | 2022 | 1232 | 2.170 |
Why?
|
| Hemodynamics | 14 | 2023 | 816 | 2.030 |
Why?
|
| Critical Illness | 11 | 2023 | 616 | 2.030 |
Why?
|
| Monitoring, Physiologic | 11 | 2022 | 371 | 1.700 |
Why?
|
| Oxygen | 8 | 2021 | 553 | 1.580 |
Why?
|
| Intensive Care Units, Pediatric | 9 | 2021 | 493 | 1.450 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 174 | 1.440 |
Why?
|
| Cardiology | 4 | 2017 | 507 | 1.420 |
Why?
|
| Oximetry | 7 | 2021 | 177 | 1.320 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 157 | 1.280 |
Why?
|
| Heart Failure | 8 | 2016 | 2307 | 1.270 |
Why?
|
| Capnography | 2 | 2020 | 13 | 1.190 |
Why?
|
| Cardiovascular System | 2 | 2023 | 103 | 1.190 |
Why?
|
| Heart Diseases | 4 | 2019 | 505 | 1.140 |
Why?
|
| Sepsis | 2 | 2023 | 501 | 1.140 |
Why?
|
| Nitric Oxide | 5 | 2019 | 466 | 0.950 |
Why?
|
| Child | 46 | 2022 | 26307 | 0.930 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2017 | 326 | 0.880 |
Why?
|
| Cardiac Output | 7 | 2022 | 152 | 0.870 |
Why?
|
| Physicians | 3 | 2022 | 634 | 0.850 |
Why?
|
| Humans | 84 | 2024 | 131759 | 0.830 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 25 | 0.820 |
Why?
|
| Heart | 4 | 2023 | 675 | 0.800 |
Why?
|
| Blood Pressure | 6 | 2022 | 1344 | 0.740 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2014 | 675 | 0.740 |
Why?
|
| Hypertension, Pulmonary | 5 | 2019 | 463 | 0.720 |
Why?
|
| Certification | 2 | 2019 | 72 | 0.710 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 487 | 0.700 |
Why?
|
| Tetralogy of Fallot | 3 | 2012 | 176 | 0.700 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 163 | 0.690 |
Why?
|
| Fontan Procedure | 1 | 2023 | 189 | 0.680 |
Why?
|
| Inflammation | 2 | 2020 | 1493 | 0.680 |
Why?
|
| Lung | 2 | 2020 | 1566 | 0.680 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3133 | 0.670 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 991 | 0.660 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 28 | 0.650 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 689 | 0.640 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8594 | 0.630 |
Why?
|
| Infant | 24 | 2020 | 13317 | 0.600 |
Why?
|
| Triiodothyronine | 1 | 2019 | 56 | 0.600 |
Why?
|
| Internationality | 1 | 2019 | 130 | 0.580 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 339 | 0.570 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 547 | 0.560 |
Why?
|
| Hypothyroidism | 1 | 2019 | 78 | 0.560 |
Why?
|
| Postoperative Care | 5 | 2020 | 303 | 0.560 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 81 | 0.550 |
Why?
|
| Curriculum | 2 | 2022 | 784 | 0.540 |
Why?
|
| Hospital Mortality | 5 | 2021 | 1076 | 0.530 |
Why?
|
| Vasopressins | 3 | 2021 | 44 | 0.510 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 3093 | 0.510 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 272 | 0.510 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 215 | 0.490 |
Why?
|
| Immunomodulation | 1 | 2016 | 80 | 0.480 |
Why?
|
| Respiratory System | 1 | 2016 | 97 | 0.480 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 109 | 0.460 |
Why?
|
| Shock | 1 | 2016 | 96 | 0.460 |
Why?
|
| Immune System Diseases | 1 | 2015 | 52 | 0.450 |
Why?
|
| Societies, Medical | 5 | 2015 | 796 | 0.450 |
Why?
|
| Clinical Competence | 2 | 2019 | 1051 | 0.450 |
Why?
|
| Child, Preschool | 18 | 2020 | 15051 | 0.430 |
Why?
|
| Congresses as Topic | 1 | 2015 | 187 | 0.420 |
Why?
|
| Child Abuse | 1 | 2017 | 223 | 0.410 |
Why?
|
| Education, Medical | 1 | 2017 | 288 | 0.410 |
Why?
|
| Shock, Septic | 1 | 2015 | 149 | 0.410 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 41 | 0.400 |
Why?
|
| Ventilator Weaning | 2 | 2010 | 30 | 0.400 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 324 | 0.400 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 301 | 0.390 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 2082 | 0.380 |
Why?
|
| Vascular Resistance | 2 | 2020 | 182 | 0.380 |
Why?
|
| Vancomycin | 1 | 2014 | 225 | 0.370 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 195 | 0.360 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.350 |
Why?
|
| Airway Extubation | 1 | 2012 | 70 | 0.350 |
Why?
|
| Length of Stay | 6 | 2021 | 1399 | 0.350 |
Why?
|
| Cardiac Output, Low | 1 | 2010 | 57 | 0.320 |
Why?
|
| Positive-Pressure Respiration | 1 | 2010 | 83 | 0.320 |
Why?
|
| Intensive Care Units | 6 | 2020 | 517 | 0.320 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 132 | 0.320 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 39 | 0.310 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 64 | 0.310 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 31 | 0.310 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12993 | 0.300 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 80 | 0.300 |
Why?
|
| Brain | 2 | 2012 | 3235 | 0.300 |
Why?
|
| Retrospective Studies | 15 | 2022 | 17662 | 0.300 |
Why?
|
| Coronary Care Units | 4 | 2020 | 33 | 0.290 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 645 | 0.290 |
Why?
|
| Diuretics | 3 | 2019 | 158 | 0.280 |
Why?
|
| Postoperative Period | 4 | 2019 | 335 | 0.280 |
Why?
|
| Respiration, Artificial | 6 | 2019 | 501 | 0.280 |
Why?
|
| Steroids | 1 | 2009 | 172 | 0.270 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 549 | 0.270 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 131 | 0.270 |
Why?
|
| Arteries | 2 | 2019 | 210 | 0.260 |
Why?
|
| Fluid Therapy | 2 | 2022 | 145 | 0.250 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2021 | 127 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 1253 | 0.250 |
Why?
|
| Hospitalization | 5 | 2021 | 1942 | 0.240 |
Why?
|
| Dexamethasone | 3 | 2005 | 262 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2024 | 303 | 0.230 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 192 | 0.230 |
Why?
|
| Respiration | 3 | 2016 | 119 | 0.230 |
Why?
|
| Prospective Studies | 7 | 2020 | 6507 | 0.220 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 340 | 0.220 |
Why?
|
| Male | 22 | 2020 | 65274 | 0.210 |
Why?
|
| Creatinine | 2 | 2017 | 402 | 0.210 |
Why?
|
| Acute Disease | 3 | 2016 | 1153 | 0.210 |
Why?
|
| Mediastinum | 1 | 2023 | 46 | 0.200 |
Why?
|
| Cause of Death | 2 | 2019 | 510 | 0.200 |
Why?
|
| Heart Rate | 3 | 2020 | 580 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 6280 | 0.200 |
Why?
|
| Female | 22 | 2020 | 71214 | 0.200 |
Why?
|
| Hemodynamic Monitoring | 1 | 2022 | 16 | 0.190 |
Why?
|
| Water | 1 | 2023 | 190 | 0.190 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 224 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2576 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 58 | 0.170 |
Why?
|
| Biological Transport | 2 | 2011 | 333 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3451 | 0.160 |
Why?
|
| Age Factors | 2 | 2019 | 2872 | 0.160 |
Why?
|
| Nicardipine | 1 | 2020 | 16 | 0.160 |
Why?
|
| Tidal Volume | 1 | 2020 | 42 | 0.160 |
Why?
|
| Nitroprusside | 1 | 2020 | 36 | 0.160 |
Why?
|
| United States | 6 | 2022 | 11812 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2020 | 55 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 135 | 0.160 |
Why?
|
| Hypotension | 1 | 2021 | 185 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2021 | 3696 | 0.150 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 516 | 0.150 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 45 | 0.150 |
Why?
|
| Acidosis | 1 | 2020 | 99 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 33 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 344 | 0.150 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 153 | 0.140 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 242 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 174 | 0.140 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 450 | 0.130 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 81 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 16 | 0.130 |
Why?
|
| Diuresis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1626 | 0.130 |
Why?
|
| Nurses | 1 | 2017 | 79 | 0.120 |
Why?
|
| Veins | 1 | 2017 | 99 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 844 | 0.120 |
Why?
|
| Adolescent | 6 | 2021 | 20987 | 0.120 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 36 | 0.120 |
Why?
|
| Alprostadil | 1 | 2015 | 22 | 0.120 |
Why?
|
| Specialization | 1 | 2016 | 75 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 10961 | 0.120 |
Why?
|
| Inpatients | 1 | 2020 | 544 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 741 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2019 | 1521 | 0.110 |
Why?
|
| Weight Gain | 1 | 2017 | 384 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2017 | 318 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 139 | 0.110 |
Why?
|
| Premedication | 2 | 2005 | 39 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2019 | 769 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1406 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 201 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 241 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5297 | 0.100 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 136 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 547 | 0.100 |
Why?
|
| Publications | 1 | 2013 | 36 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 570 | 0.100 |
Why?
|
| Global Health | 1 | 2017 | 632 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 215 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2020 | 1224 | 0.090 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 5 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 200 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 207 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1216 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 1838 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2016 | 557 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 34404 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 401 | 0.090 |
Why?
|
| Texas | 3 | 2015 | 3622 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 191 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 118 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1360 | 0.090 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 267 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1235 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 3836 | 0.080 |
Why?
|
| Calcium | 1 | 2016 | 1041 | 0.080 |
Why?
|
| California | 1 | 2010 | 128 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 80 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1309 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 86 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 1597 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 27 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 793 | 0.070 |
Why?
|
| Reperfusion | 1 | 2009 | 26 | 0.070 |
Why?
|
| Pressure | 1 | 2009 | 126 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 82 | 0.070 |
Why?
|
| Biomarkers | 2 | 2014 | 3407 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 209 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 210 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 359 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 3349 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2390 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 97 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 695 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1303 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1413 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2024 | 32 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 350 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1348 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 25 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 123 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 16 | 0.040 |
Why?
|
| Calcium Chloride | 1 | 2021 | 23 | 0.040 |
Why?
|
| Morbidity | 2 | 2015 | 261 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 4953 | 0.040 |
Why?
|
| Complement C3a | 1 | 2000 | 18 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 173 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2003 | 1638 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 144 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 94 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 128 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 248 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 428 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 217 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 131 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2000 | 419 | 0.030 |
Why?
|
| Neutrophils | 1 | 2000 | 372 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 643 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 57 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 531 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 35 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 242 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2019 | 233 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 441 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 232 | 0.030 |
Why?
|
| Bradycardia | 1 | 2014 | 57 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 18 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7576 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1170 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 17 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 251 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 41 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 234 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2014 | 181 | 0.020 |
Why?
|
| Troponin | 1 | 2012 | 70 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 31700 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 762 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 709 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 1695 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2014 | 423 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1483 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 974 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 595 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1457 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2221 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 282 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 10099 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 215 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 432 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21259 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 955 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28892 | 0.010 |
Why?
|